| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.2 |